BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9679752)

  • 1. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer.
    Nozawa H; Oda E; Ueda S; Tamura G; Maesawa C; Muto T; Taniguchi T; Tanaka N
    Int J Cancer; 1998 Aug; 77(4):522-7. PubMed ID: 9679752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach.
    Tamura G; Ogasawara S; Nishizuka S; Sakata K; Maesawa C; Suzuki Y; Terashima M; Saito K; Satodate R
    Cancer Res; 1996 Feb; 56(3):612-5. PubMed ID: 8564980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss on chromosomes 3p, 5q and 17p in renal cell carcinomas.
    Sugimura J; Tamura G; Suzuki Y; Fujioka T
    Pathol Int; 1997; 47(2-3):79-83. PubMed ID: 9088024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
    Willman CL; Sever CE; Pallavicini MG; Harada H; Tanaka N; Slovak ML; Yamamoto H; Harada K; Meeker TC; List AF
    Science; 1993 Feb; 259(5097):968-71. PubMed ID: 8438156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct regions of frequent loss of heterozygosity of chromosome 5p and 5q in human esophageal cancer.
    Peralta RC; Casson AG; Wang RN; Keshavjee S; Redston M; Bapat B
    Int J Cancer; 1998 Nov; 78(5):600-5. PubMed ID: 9808529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A candidate tumor suppressor locus for scirrhous gastric cancer at chromosome 18q 12.2.
    Nishioka N; Yashiro M; Inoue T; Matsuoka T; Ohira M; Chung KH
    Int J Oncol; 2001 Feb; 18(2):317-22. PubMed ID: 11172598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fez1/lzts1 alterations in gastric carcinoma.
    Vecchione A; Ishii H; Shiao YH; Trapasso F; Rugge M; Tamburrino JF; Murakumo Y; Alder H; Croce CM; Baffa R
    Clin Cancer Res; 2001 Jun; 7(6):1546-52. PubMed ID: 11410489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2.
    Harada H; Kitagawa M; Tanaka N; Yamamoto H; Harada K; Ishihara M; Taniguchi T
    Science; 1993 Feb; 259(5097):971-4. PubMed ID: 8438157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31).
    Green WB; Slovak ML; Chen IM; Pallavicini M; Hecht JL; Willman CL
    Leukemia; 1999 Dec; 13(12):1960-71. PubMed ID: 10602416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias.
    Beretta L; Gabbay M; Berger R; Hanash SM; Sonenberg N
    Oncogene; 1996 Apr; 12(7):1593-6. PubMed ID: 8622878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate regions of tumor suppressor locus on chromosome 9q31.1 in gastric cancer.
    Kakinuma N; Kohu K; Sato M; Yamada T; Nakajima M; Akiyama T; Ohwada S; Shibanaka Y
    Int J Cancer; 2004 Mar; 109(1):71-5. PubMed ID: 14735470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
    Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
    Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.
    Bouker KB; Skaar TC; Riggins RB; Harburger DS; Fernandez DR; Zwart A; Wang A; Clarke R
    Carcinogenesis; 2005 Sep; 26(9):1527-35. PubMed ID: 15878912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding.
    Eason DD; Shepherd AT; Blanck G
    Biochim Biophys Acta; 1999 Jul; 1446(1-2):140-4. PubMed ID: 10395927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
    Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S
    Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts.
    Contente S; Attard FA; Yeh TJ; Buchhagen DL; Friedman RM
    J Interferon Cytokine Res; 2003 Nov; 23(11):639-47. PubMed ID: 14651778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragenic homozygous deletions of MTS1 gene in gastric cancer in Taiwan.
    Wu MS; Lin YW; Sheu JC; Wang HP; Wang JT; Shun CT; Lee WJ; Wang TH; Lin JT
    Jpn J Cancer Res; 1996 Oct; 87(10):1052-5. PubMed ID: 8957063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
    Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade gastric adenomas/dysplasias: phenotypic expression, DNA ploidy pattern, and LOH at microsatellites linked to the APC gene.
    Tanaka A; Takemura-Tsukashita S; Kushima R; Sugihara H; Fujiyama Y; Hattori T
    Pathol Res Pract; 2008; 204(1):1-9. PubMed ID: 17964080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.